Back
iShares Emerging Markets Dividend ETF Vs. Regencell Bioscience Holdings Ltd. Sector Stock Comparison
Buy
62
DVYE
iShares Emerging Markets Dividend ETF
Last Price:
$31.79
Seasonality Move:
-0.16%
Buy
70
RGC
Regencell Bioscience Holdings Ltd.
Last Price:
$41.51
Seasonality Move:
69.73%
Buy
62
iShares Emerging Markets Dividend ETF (DVYE)
is a Buy
Is iShares Emerging Markets Dividend ETF a Buy, Sell or Hold?
-
The current iShares Emerging Markets Dividend ETF [DVYE] share price is $31.79. The Score for DVYE is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
DVYE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Regencell Bioscience Holdings Ltd. (RGC)
is a Buy
Is Regencell Bioscience Holdings Ltd. a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings Ltd. [RGC] share price is $52.88. The Score for RGC is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
RGC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DVYE Stock Price Chart
What is iShares Emerging Markets Dividend ETF's stock price today?
-
The iShares Emerging Markets Dividend ETF share price today is $31.79Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DVYE is experiencing selling pressure, which indicates risk of future bearish movement.
RGC Stock Price Chart
What is Regencell Bioscience Holdings Ltd.'s stock price today?
-
The Regencell Bioscience Holdings Ltd. share price today is $52.88Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing buying pressure, which is a positive indicator for future bullish movement.
DVYE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 64.32 | Buy |
| Chaikin Money Flow: | -266971 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.77 - 31.47) | Buy |
| Bollinger Bands (100): | (29.61 - 31.11) | Buy |
RGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.21 | Buy |
| Relative Strength Index (14 RSI): | 87.06 | Buy |
| Chaikin Money Flow: | 2558033 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.04 - 28.92) | Buy |
| Bollinger Bands (100): | (11.09 - 21.37) | Buy |
DVYE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.38 | Buy |
| 20-day SMA: | 31.07 | Buy |
| 50-day SMA: | 31.01 | Buy |
| 200-day SMA: | 29.18 | Buy |
| 8-day EMA: | 31.44 | Buy |
| 20-day EMA: | 31.2 | Buy |
| 50-day EMA: | 30.88 | Buy |
| 200-day EMA: | 29.52 | Buy |
RGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.75 | Buy |
| 20-day SMA: | 22.49 | Buy |
| 50-day SMA: | 17.26 | Buy |
| 200-day SMA: | 14.27 | Buy |
| 8-day EMA: | 31.19 | Buy |
| 20-day EMA: | 24.47 | Buy |
| 50-day EMA: | 19.59 | Buy |
| 200-day EMA: | 13.98 | Buy |
iShares Emerging Markets Dividend ETF Earnings Growth & DVYE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Regencell Bioscience Holdings Ltd. Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
iShares Emerging Markets Dividend ETF Technical Analysis
| Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regencell Bioscience Holdings Ltd. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||